4 Results for "

JAK isoforms

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "JAK isoforms" in MCE Product Catalog:

Cat. No.: HY-151385
CAS No.: 2875046-27-6
Purity:  99.75%
Research Areas:  

Cancer

VVD-118313 (compound 5a) is a potent, selective JAK1 inhibitor. VVD-118313 targets an isoform-restricted allosteric cysteine to block JAK1-dependent trans-phosphorylation and cytokine signaling. VVD-118313 can be used for research of cancer . VVD-118313 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-146727
CAS No.: 2412734-00-8
Target:  

JAK

Research Areas:  

Inflammation/Immunology

JAK3-IN-11 (Compound 12), a potent, noncytotoxic, irreversible, orally active JAK3 inhibitor with IC50 value of 1.7 nM, has excellent selectivity (>588-fold compared to other JAK isoforms), covalently bind to the ATP-binding pocket in JAK3. JAK3-IN-11 strongly inhibits JAK3-dependent signaling and T cell proliferation, is a promising tool for study autoimmune diseases .
loading...
    loading...
Cat. No.: HY-10652
CAS No.: 1036241-36-7
Target:  

JAK

Research Areas:  

Inflammation/Immunology Cancer

JAK-2/3-IN-1 is a potent JAK-2 and JAK-3 inhibitor extracted from patent US8163732B2, compound 46, has Kis of <250 nM for both isoforms .
loading...
    loading...
Cat. No.: HY-178913
CAS No.: 2734918-75-1
Target:  

JAK STAT

Research Areas:  

Inflammation/Immunology

Tyk2-IN-23 is a potent, orally active, selective TYK2 inhibitor (IC50 = 18 nM), exhibiting more than > 70-fold selectivity over JAK1/2/3 isoforms. Tyk2-IN-23 potently inhibits p-STAT3 in TYK2-dependent signaling activated by IFN-α and IL-10. Tyk2-IN-23 potently inhibits IFN-α-induced STAT1 phosphorylation in H9 cells. Tyk2-IN-23 can be used for the study of alopecia areata and allergic Rhinitis .
loading...
    loading...